“…1 Among them, 1,2,4-triazolo [1,5-a]pyridines which are considered as a unique category of N-bridged 5,6bicyclic compounds have received substantial consideration for either their potential utility as bioactive precursors or for other industrial applications. 2,3 For example, they exhibit several pharmaceutical behaviors including, mGlu modulation, 4 PHD-1 inhibition, 5 PDE10 inhibition, 6 and acting as an antioxidant. 7 In addition examples of these compounds have been utilized as herbicidal agents 8 and for treatment of diabetes (type-II), 9,10 cardiovascular disorders, 11 and hyperproliferative disorders.…”